{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:12:45Z","timestamp":1774393965272,"version":"3.50.1"},"reference-count":54,"publisher":"Impact Journals, LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2021,2,28]]},"DOI":"10.18632\/aging.202427","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T12:36:16Z","timestamp":1612182976000},"page":"5087-5103","source":"Crossref","is-referenced-by-count":11,"title":["Integrative transcriptomic and metabonomic profiling analyses reveal the molecular mechanism of Chinese traditional medicine huankuile suspension on TNBS-induced ulcerative colitis"],"prefix":"10.18632","volume":"13","author":[{"given":"Zhenglan","family":"Han","sequence":"first","affiliation":[{"name":"Department of Biochemistry, School of Preclinical Medicine, North Sichuan Medical College, Nanchong 637100, Sichuan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, School of Preclinical Medicine, North Sichuan Medical College, Nanchong 637100, Sichuan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, School of Preclinical Medicine, North Sichuan Medical College, Nanchong 637100, Sichuan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, School of Preclinical Medicine, North Sichuan Medical College, Nanchong 637100, Sichuan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2021,2,1]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/gut.2010.224154","article-title":"Guidelines for the management of inflammatory bowel disease in adults.","volume":"6","author":"Bloom","year":"2011","journal-title":"Gut"},{"key":"2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/ajg.2009.727","article-title":"Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee.","volume":"10","author":"Sachar","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"3","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1172\/JCI30587","article-title":"The fundamental basis of inflammatory bowel disease.","volume":"11","author":"Mannon","year":"2007","journal-title":"J Clin Invest"},{"key":"4","doi-asserted-by":"publisher","first-page":"9458","DOI":"10.3748\/wjg.v20.i28.9458","article-title":"Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis.","volume":"2","author":"Santana","year":"2014","journal-title":"World J Gastroenterol"},{"key":"5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","article-title":"Epidemiology and risk factors for IBD.","volume":"1","author":"Ananthakrishnan","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"6","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences.","volume":"12","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"key":"7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41575-019-0248-1","article-title":"Host-microbiota interactions in inflammatory bowel disease.","volume":"1","author":"Neurath","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cellimm.2007.02.004","article-title":"Autoantibodies against human tropomyosin isoform 5 in ulcerative colitis destroys colonic epithelial cells through antibody and complement-mediated lysis.","volume":"24","author":"Das","year":"2006","journal-title":"Cell Immunol"},{"key":"9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/17402520400004201","article-title":"Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis?","volume":"1","author":"Fiocchi","year":"2004","journal-title":"Clin Dev Immunol"},{"key":"10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/gast.2002.30294","article-title":"Mucosal flora in inflammatory bowel disease.","volume":"12","author":"Lochs","year":"2002","journal-title":"Gastroenterology"},{"key":"11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/ncpgasthep0528","article-title":"Mechanisms of disease: pathogenesis of Crohn\u2019s disease and ulcerative colitis.","volume":"3","author":"Sartor","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"12","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","article-title":"Inflammatory bowel disease: cause and immunobiology.","volume":"36","author":"Carding","year":"2007","journal-title":"Lancet"},{"key":"13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1515\/jbcpp-2016-0014","article-title":"Pharmacotherapy of ulcerative colitis - current status and emerging trends.","volume":"2","author":"Kumar","year":"2018","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"14","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1080\/14656566.2018.1525361","article-title":"Nonbiological therapeutic management of ulcerative colitis.","volume":"1","author":"Ardizzone","year":"2018","journal-title":"Expert Opin Pharmacother"},{"key":"15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1586\/ecp.12.2","article-title":"Mesalamine in the treatment and maintenance of remission of ulcerative colitis.","volume":"5","author":"Moss","year":"2012","journal-title":"Expert Rev Clin Pharmacol"},{"key":"16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1365-2036.2006.02761.x","article-title":"Review article: complementary and alternative therapies for inflammatory bowel disease.","volume":"2","author":"Rampton","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"17","first-page":"163","article-title":"Clinical study on 118 cases of ulcerative colitis treated by integration of traditional Chinese and western medicine.","volume":"1","author":"Zhang","year":"1999","journal-title":"J Tradit Chin Med"},{"key":"18","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41598-017-01335-w","article-title":"A Systems Pharmacology Approach to Determine Active Compounds and Action Mechanisms of Xipayi KuiJie'an enema for Treatment of Ulcerative colitis.","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12906-015-0672-x","article-title":"Uygur medicine Xipayi Kui Jie\u2019an affects gene expression profiles in intestinal tissue lesions in a rat model of ulcerative colitis.","volume":"1","author":"Upur","year":"2015","journal-title":"BMC Complement Altern Med"},{"key":"20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S1875-5364(19)30012-3","article-title":"Progress in active compounds effective on ulcerative colitis from Chinese medicines.","volume":"1","author":"Pu","year":"2019","journal-title":"Chin J Nat Med"},{"key":"21","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.3748\/wjg.v23.i16.2819","article-title":"High throughput RNA sequencing utility for diagnosis and prognosis in colon diseases.","volume":"2","author":"Vyas","year":"2017","journal-title":"World J Gastroenterol"},{"key":"22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11306-017-1311-y","article-title":"Alterations in lipid, amino acid, and energy metabolism distinguish Crohn\u2019s disease from ulcerative colitis and control subjects by serum metabolomic profiling.","volume":"1","author":"Coburn","year":"2018","journal-title":"Metabolomics"},{"key":"23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/metabo9120291","article-title":"Mucosal metabolomic profiling and pathway analysis reveal the metabolic signature of ulcerative colitis.","volume":"9","author":"Forsdahl","year":"2019","journal-title":"Metabolites"},{"key":"24","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/ibd\/izy402","article-title":"Untargeted metabolomics and inflammatory markers profiling in children with Crohn\u2019s disease and ulcerative colitis-A preliminary study.","volume":"2","author":"Ciborowski","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"25","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMra1102942","article-title":"Ulcerative colitis.","volume":"36","author":"Fiocchi","year":"2011","journal-title":"N Engl J Med"},{"key":"26","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.3390\/ijms13032877","article-title":"An oligodeoxynucleotide that induces differentiation of bone marrow mesenchymal stem cells to osteoblastsand reduces alveolar bone loss in rats with periodontitis.","volume":"1","author":"Sun","year":"2012","journal-title":"Int J Mol Sci"},{"key":"27","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1111\/j.1572-0241.1999.01372.x","article-title":"Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: correlation with disease activity.","volume":"9","author":"Shimizu","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"28","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3892\/ijmm.2013.1287","article-title":"Aberrant expression of circulating Th17, Th1 and Tc1 cells in patients with active and inactive ulcerative colitis.","volume":"3","author":"Wang","year":"2013","journal-title":"Int J Mol Med"},{"key":"29","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis.","volume":"38","author":"Colombel","year":"2017","journal-title":"Lancet"},{"key":"30","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ni.2920","article-title":"TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells.","volume":"1","author":"Neurath","year":"2014","journal-title":"Nat Immunol"},{"key":"31","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/MIB.0000000000000035","article-title":"Mucosal toll-like receptor 3-dependent synthesis of complement factor B and systemic complement activation in inflammatory bowel disease.","volume":"2","author":"Sandvik","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.molimm.2017.08.003","article-title":"Regulation of epithelial cell expressed C3 in the intestine - Relevance for the pathophysiology of inflammatory bowel disease?","volume":"9","author":"Derer","year":"2017","journal-title":"Mol Immunol"},{"key":"33","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/0016-5085(90)90343-Y","article-title":"Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis.","volume":"9","author":"Brandtzaeg","year":"1990","journal-title":"Gastroenterology"},{"key":"34","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1097\/MIB.0000000000000056","article-title":"The complement system in inflammatory bowel disease.","volume":"2","author":"Stadnyk","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"35","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2174\/13894501113149990162","article-title":"PPAR-gamma in ulcerative colitis: a novel target for intervention.","volume":"1","author":"Desreumaux","year":"2013","journal-title":"Curr Drug Targets"},{"key":"36","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/01.MIB.0000218764.06959.91","article-title":"Critical role of IL-17 receptor signaling in acute TNBS-induced colitis.","volume":"1","author":"Kolls","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/prd.12083","article-title":"Basic biology and role of interleukin-17 in immunity and inflammation.","volume":"6","author":"Hajishengallis","year":"2015","journal-title":"Periodontol 2000"},{"key":"38","doi-asserted-by":"publisher","first-page":"10176","DOI":"10.1038\/s41598-019-46671-1","article-title":"Therapeutic effect of gold nanoparticles on DSS-induced ulcerative colitis in mice with reference to interleukin-17 expression.","volume":"9","author":"Kattaia","year":"2019","journal-title":"Sci Rep"},{"key":"39","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.plipres.2016.09.003","article-title":"DHCR7: a vital enzyme switch between cholesterol and vitamin D production.","volume":"6","author":"Brown","year":"2016","journal-title":"Prog Lipid Res"},{"key":"40","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.12688\/f1000research.15500.1","article-title":"Cholesterol metabolism in innate and adaptive response.","volume":"7","author":"Dang","year":"2018","journal-title":"F1000Res"},{"key":"41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.immuni.2019.11.015","article-title":"Targeting 7-dehydrocholesterol reductase integrates cholesterol metabolism and IRF3 activation to eliminate infection.","volume":"5","author":"Qiu","year":"2020","journal-title":"Immunity"},{"key":"42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cbi.2018.05.012","article-title":"Serum derived from ulcerative colitis mouse changes the metabolism of the fluorescent substrate by P450 depending on the degree of disease progression.","volume":"29","author":"Imaishi","year":"2018","journal-title":"Chem Biol Interact"},{"key":"43","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/j.crohns.2012.04.019","article-title":"Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy.","volume":"7","author":"Slupsky","year":"2013","journal-title":"J Crohns Colitis"},{"key":"44","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3748\/wjg.v20.i1.163","article-title":"Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.","volume":"2","author":"Korta","year":"2014","journal-title":"World J Gastroenterol"},{"key":"45","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.bbrc.2013.03.012","article-title":"1H NMR-based spectroscopy detects metabolic alterations in serum of patients with early-stage ulcerative colitis.","volume":"43","author":"Zheng","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"46","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.3748\/wjg.v23.i21.3890","article-title":"Dietary and metabolomic determinants of relapse in ulcerative colitis patients: a pilot prospective cohort study.","volume":"2","author":"Dieleman","year":"2017","journal-title":"World J Gastroenterol"},{"key":"47","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s00011-011-0340-7","article-title":"GC\/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis.","volume":"6","author":"Yoshida","year":"2011","journal-title":"Inflamm Res"},{"key":"48","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000505368","article-title":"Nutrition in Inflammatory Bowel Disease","volume":"10","author":"Biedermann","year":"2020","journal-title":"Digestion"},{"key":"49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MOG.0000000000000449","article-title":"Vitamin D in inflammatory bowel disease: more than just a supplement.","volume":"3","author":"Moss","year":"2018","journal-title":"Curr Opin Gastroenterol"},{"key":"50","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.gtc.2017.08.011","article-title":"Vitamins and minerals in inflammatory bowel disease.","volume":"4","author":"Kiela","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"key":"51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/CEG.S186097","article-title":"A pilot study of fecal bile acid and microbiota profiles in inflammatory bowel disease and primary sclerosing cholangitis.","volume":"1","author":"Khoruts","year":"2019","journal-title":"Clin Exp Gastroenterol"},{"key":"52","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1586\/egh.09.49","article-title":"Chronic diarrhea caused by idiopathic bile acid malabsorption: an explanation at last.","volume":"3","author":"Hofmann","year":"2009","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"53","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.intimp.2019.04.052","article-title":"Regulating effect of baicalin on IKK\/IKB\/NF-kB signaling pathway and apoptosis-related proteins in rats with ulcerative colitis.","volume":"7","author":"Zheng","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"54","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1046\/j.1365-2249.1998.00728.x","article-title":"Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.","volume":"11","author":"Van Rees","year":"1998","journal-title":"Clin Exp Immunol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.202427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T16:16:27Z","timestamp":1617725787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.202427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,2,28]]}},"alternative-id":["202427","33535180"],"URL":"https:\/\/doi.org\/10.18632\/aging.202427","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,1]]}}}